Clinical trial delays: How packaging experts can help reduce timelines through early protocol development
It’s the age-old riddle – what can be kept but never held? Time. When clinical trials get delayed, they steal precious time from earlier access to life-changing therapies, impacting trial start dates and patient recruitment. There are even implications for regulatory compliance, where extended timelines could derail clinical trials that are subject to heightened data scrutiny.
Then, there’s the other side of the coin, where even those in the supply chain can ultimately delay a critical pharmaceutical product from entering or re-entering the market. Think back to 2023/2024 when ibuprofen prices surged due to global demand after the pharma supply chain suffered from production constraints and rising energy costs. Or even in 2025, where surging tariffs on medicines caused supply chain disruptions and led to higher costs.
Where clinical trial delays typically occur
Delays can therefore accumulate anywhere in the supply chain. Packaging is one of the areas where common bottlenecks often arise, especially if packaging specifications haven’t been considered during protocol development. Between pharmaceutical packaging design and artwork iterations, to late-stage amendments and regulatory rework, packaging that hasn’t been designed with flexibility in mind, or has been developed under compressed timelines, ultimately results in increased error risk and further delays. But if time cannot be held, is there a reason why it cannot be gained? Smarter packaging from MM Pharma & HC Packaging could be the answer.
Turning packaging into a timeline accelerator
Early planning with experienced packaging partners transforms these vulnerabilities into important competitive advantages. At MM Pharma & HC Packaging, we understand how important it is to provide products of the highest quality – it’s one of our core business pillars. As specialists in pharmaceutical secondary packaging and clinical trial packaging solutions, we keep abreast of the global regulatory frameworks to anticipate labelling requirements and prevent unwanted late-stage surprises. With over 35 years of experience in clinical trials, our team of experts are highly equipped to spot even the smallest of errors, so sponsors can rest assured that they are in good hands.
Working with a pharma packaging specialist like us helps you gain time in areas like artwork approvals or validation cycles too. There is no need to sacrifice quality when involving experts early in the decision-making process as there is mutual understanding when it comes to patient needs. For example, optimising kit designs for intuitive use or including smart packaging solutions such as NFC tags, RFID labels and Time Temperature Indicators, can all make a difference when taken into consideration early in the protocol approval process.
Without specialist involvement, quality failures can lead very quickly to further investigations and missed timelines. Imagine if your inventory control system failed, the business outcome could be disastrous. Clinical trials need the same forethought. If inventory control systems are instrumental to your business, then the same consideration must be given to the packaging process. Getting it right first time with quality is not a cost or a control step, it is a time protection mechanism in clinical trials.
Reducing clinical trial delays starts with smarter packaging
Let’s be clear: packaging and the pharma supply chain must work as one system to lessen the impact on clinical trial delays. With many suppliers in the chain, often with their own organisational standardisations, there’s more chance delays could occur. And while it’s often easier said than done to have fewer suppliers in the chain, MM Pharma & HC Packaging has the flexibility, expertise and over 30 years of experience in handling unpredictable demand on a global scale. Our Clinical Trial Packaging service delivers the full works and is trusted by pharmaceutical companies, CROs, and CDMOs worldwide. From a full-service design-to-pack to tailored labelling solutions that are engineered with speed and scalability front of mind, our dedicated quality teams ensure that your clinical packaging meets the highest global pharmaceutical regulations.
Delays don’t have to be inevitable. Involving packaging specialists like MM Pharma & HC Packaging from the outset means you could save weeks – if not months – on a clinical trial timeline. In an industry where every day matters and patients’ livelihoods are at stake, a strategic partnership with your packaging partner may be the most valuable investment a pharmaceutical company can make.
